SB-656933 Tablets ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	1
299	Cystic fibrosis	1

97. Ulcerative colitis

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-005520-32-NL (EUCTR)	01/10/2008	05/08/2008	An open label, 7-day repeat dose study to evaluate the pharmacodynamics of SB-656933-AAA in patients ...	An open label, 7-day repeat dose study to evaluate the pharmacodynamics of SB-656933-AAA in patients ...	ulcerative colitis MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative coli ...	Product Name: SB-656933 Tablets Product Code: SB-656933	GlaxoSmithKline R&D Ltd	NULL	Not Recruiting			Female: yes Male: yes			Netherlands

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-018738-27-DE (EUCTR)	02/06/2010	16/03/2010	A Randomized, Double Blind, Parallel Group, Placebo Controlled 28 Day Study to Investigate the Safet ...	A Randomized, Double Blind, Parallel Group, Placebo Controlled 28 Day Study to Investigate the Safet ...	Cystic fibrosis MedDRA version: 12.1;Level: LLT;Classification code 10011763;Term: Cystic fibrosis l ...	Product Name: SB-656933 Tablets Product Code: SB-656933-AAA Product Name: SB-656933 Tablets Product Cod ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	100		Germany